ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.320
-0.020 (-1.49%)
May 13, 2025, 4:00 PM - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $130.92 million as of May 14, 2025. Its market cap has decreased by -64.40% in one year.
Market Cap
130.92M
Enterprise Value
323.14M
1-Year Change
-64.40%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $130.92M, a decrease of -93.59%. That is a compound annual growth rate of -42.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 132.90M | -30.93% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |